Department of Otorhinolaryngology and Plastic Surgery, University of Luebeck, Ratzeburger Allee 160, 23562 Luebeck, Germany; Department of Surgery, University Medical Center Regensburg, Franz-Josef-Strauß-Allee 11, 93053 Regensburg, Germany.
Department of Otorhinolaryngology and Plastic Surgery, University of Luebeck, Ratzeburger Allee 160, 23562 Luebeck, Germany; Department of Internal Medicine, University Medical Center Regensburg, Franz-Josef-Strauß-Allee 11, 93053 Regensburg, Germany.
Eur J Cancer. 2014 Aug;50(12):2152-61. doi: 10.1016/j.ejca.2014.05.005. Epub 2014 Jun 7.
Membrane-bound complement restriction proteins (mCRPs) CD46, CD55 and CD59 enable tumour cells to evade complement dependent cytotoxicity and antibody-dependent killing mechanisms. But less is known about the role of these mCRPs in head and neck cancer.
In this study we determined the expression of the mCRPs on head and neck squamous cell carcinoma (HNSCC) cell lines, on tumour tissue and TDLNs (tumour-draining lymph nodes) as well as on lymphocytes from HNSCC patients. The influence of the HNSCC microenvironment on the mCRP regulation was analysed using Flow Cytometry, Western blotting and small interfering RNAs (siRNA) transfection studies.
We examined the effects of the HNSCC tumour milieu on the expression levels of CD46, CD55 and CD59. We investigated the susceptibility of HNSCC cells to CDC (complement-dependent cytotoxicity) while silencing the mCRPs. Our results demonstrate a huge influence of the HNSCC tumour microenvironment on the regulation of mCRP expression and show a reciprocal regulation between the different mCRPs themselves.
In summary, our data indicate that HNSCC has evolved different strategies to evade complement attacks and that the tumour microenvironment leads to the enhancement of complement resistance of the surrounding tissue.
膜结合补体限制蛋白(mCRPs)CD46、CD55 和 CD59 使肿瘤细胞能够逃避补体依赖的细胞毒性和抗体依赖的杀伤机制。但对于这些 mCRPs 在头颈部癌症中的作用知之甚少。
在这项研究中,我们确定了 mCRPs 在头颈部鳞状细胞癌(HNSCC)细胞系、肿瘤组织和 TDLNs(肿瘤引流淋巴结)以及 HNSCC 患者的淋巴细胞上的表达。使用流式细胞术、Western blot 和小干扰 RNA(siRNA)转染研究分析了 HNSCC 微环境对 mCRP 调节的影响。
我们研究了 HNSCC 肿瘤环境对 CD46、CD55 和 CD59 表达水平的影响。我们研究了沉默 mCRPs 时 HNSCC 细胞对 CDC(补体依赖性细胞毒性)的敏感性。我们的结果表明 HNSCC 肿瘤微环境对 mCRP 表达的调节有巨大影响,并显示不同 mCRPs 之间存在相互调节。
综上所述,我们的数据表明,HNSCC 已经进化出不同的策略来逃避补体攻击,并且肿瘤微环境导致周围组织的补体抗性增强。